Case study: printing powders with Sticky Web technology - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Case study: printing powders with Sticky Web technology


Pharmaceutical Technology Europe
Volume 21, Issue 11


Figure 1
Figure 1 shows a powder dispensing drum and coated film web ready for die cutting into individual doses. Each 2cm diameter area shown contains approximately 4.7 mg of API. The substrate is approximately 30 μm thick, giving a total coated thickness of approximately 100 μm, which allows the films to be easily rolled or folded for encapsulation or further processing. The technology also enables packaging processes to be fully merged and automated into a complete, continuous commercial production line.


Figure 2
Figure 2 shows a 3D computer-aided design model of a test rig unit delivering one dose per second. Further optimization, however, could improve this rate; for example, a multiple lane production machine with 16 lines in parallel would deliver approximately 60000 doses per hour.

Web films, adhesives and dissolution

Aside from the powderdispensing module, the other two main system components are the web or film carrier and the printable adhesive.

Edible or inert films have been widely used within the food processing industry for years because they are safe to ingest, while also being robust and flexible enough for standard web handling. Growing interest in thin-film drug delivery and controlledrelease encapsulation technologies has also generated unusual new films and materials that can be exploited within the sticky web process.

As part of the development programme, 42T investigated existing edible pressure-sensitive adhesives (PSA) and developed a range of new substances, which offer instant tack in the dry state and gently adhere to the steel powderdispensing drum, but also peel without leaving any residue. In addition, these new adhesives offer good powder adhesion and dissolve readily in water.


Figure 3
Figure 3 shows a 20× magnification of a typical powdered area generated with one of these new adhesives; the edges are clean, and there is even powder distribution and adherence of large and small particles within the sample.

Future developments

The bulk of development activity so far has been angled towards the pharmaceutical sector using edible flat carriers, but the adhesive could just as easily be printed onto other surfaces, including bubbles or tablets, which are then subsequently dosed with powders. Two or more substances could even be combined in the same delivery package.

The technology is also viable for virtually any industry requiring accurate, high-volume dosing of powders to improve existing manufacturing processes or generate innovative new products or processes.

"Sticky Web offers considerable promise for high-speed production environments where online inspection systems could be used to validate every powdered area and to improve process feedback, increase efficiency and reduce costs," said Smith.

One of the most interesting features of Sticky Web is the potential for improved release of active powders that have a tendency to agglomerate during dissolution when delivered via powder-coated films compared with capsules. Some initial development work has suggested a marked improvement, but further validation studies would be required for specific adhesive and powder combinations.

Howard Biddle is Managing Director of 42 Technology (UK).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
18%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology Europe,
Click here